文献速递慢性肾脏病肾血管病与高血压

日本慢性肾脏病患者的心血管事件与死亡

Cardiovascular events and death in Japanese patients with chronic kidney disease.
PubMed 文献 · Kidney Int · 2016-11-22

日本慢性肾脏病队列(CKD-JAC)研究纳入2966例eGFR 10-59 ml/min/1.73 m²、接受肾科医生诊疗的日本患者,随访中位3.9年。心血管事件发生率随eGFR下降而升高,仅CKD G5期较G3a期风险显著增加(HR 3.16,95%CI 1.28-7.76)。

要点

  • eGFR 45-59、30-44、15-29、<15 ml/min/1.73 m²组心血管事件发生率分别为11.9、19.1、25.0、39.4/1000人年。
  • 仅CKD G5期较G3a期心血管事件风险显著增加(HR 3.16,95%CI 1.28-7.76)。
  • 心血管病和全因死亡风险与eGFR下降相关,但未必随CKD分期进展成比例升高。

核心结论

  • 日本透析前慢性肾脏病患者的心血管病和全因死亡风险与eGFR下降相关,但风险未必随CKD分期进展成比例升高。

研究设计与样本

  • 慢性肾脏病日本队列(CKD-JAC)研究,为期四年,纳入日本17家医疗机构中接受肾科医生诊疗的2966例eGFR 10-59 ml/min/1.73 m²的慢性肾脏病患者。

主要发现

  • 中位随访3.9年期间,69例死亡,217例发生心血管事件,514例开始维持性透析治疗。
  • eGFR 45-59、30-44、15-29、<15 ml/min/1.73 m²组的心血管事件发生率分别为11.9、19.1、25.0、39.4/1000人年。
  • 校正Cox比例风险模型显示心血管事件风险随eGFR下降而增加,仅CKD G5期(eGFR<15 ml/min/1.73 m²)与CKD G3a期(eGFR 45-59 ml/min/1.73 m²)之间差异显著(HR 3.16,95%CI 1.28-7.76)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The incidence of cardiovascular disease (CVD) is higher in patients with chronic kidney disease (CKD) than in the general population, and the risk of CVD increases with reductions in renal function. However, the incidence of CVD in Japanese patients with CKD has not been sufficiently investigated. To measure this we conducted the Chronic Kidney Disease Japan Cohort (CKD-JAC) Study over four years in 2,966 Japanese patients with CKD to examine the incidence of CVD and all-cause death. These patients had an estimated glomerular filtration rate (eGFR) of 10-59 ml/min/1.73 m2, were under nephrologist care, and pooled from 17 medical institutions in Japan. At the median follow-up of 3.9 years, 69 patients had died, 217 had cardiovascular events, and 514 started maintenance dialysis therapy. The incidences of cardiovascular events were 11.9, 19.1, 25.0, and 39.4 per 1,000 person-years at eGFRs of 45-59, 30-44, 15-29, and under 15 ml/min/1.73 m2, respectively. The adjusted Cox proportional hazards models showed that the risk of cardiovascular events increased as the eGFR decreased, with a significant difference only between CKD stage G5 (eGFR: under 15 ml/min/1.73 m2) and CKD stage G3a (eGFR: 45-59 ml/min/1.73 m2) (hazard ratio 3.16, 95% confidence interval 1.28 to 7.76). Thus, the risk of CVD and all-cause death was related to the decrease in eGFR, but not necessarily elevated in proportion to progression of the CKD stage in Japanese patients with predialysis CKD under a nephrologist's care.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Tanaka K, Watanabe T, Takeuchi A, et al. Cardiovascular events and death in Japanese patients with chronic kidney disease. Kidney Int. 2016. PMID: 27884399. doi:10.1016/j.kint.2016.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。